Current position:Home >Product >
		
		
	
4-[4-(2,3-dihydroindol-1-ylmethyl)-5-methyl-1,3-oxazol-2-yl]-N-[(2-methoxyphenyl)methyl]benzamide
4-[4-(2,3-dihydroindol-1-ylmethyl)-5-methyl-1,3-oxazol-2-yl]-N-[(2-methoxyphenyl)methyl]benzamide
| 
 |  | 
Canonical SMILES:
CC1=C(N=C(O1)C2=CC=C(C=C2)C(=O)NCC3=CC=CC=C3OC)CN4CCC5=CC=CC=C54
Isomeric SMILES
CC1=C(N=C(O1)C2=CC=C(C=C2)C(=O)NCC3=CC=CC=C3OC)CN4CCC5=CC=CC=C54
InChI
InChI=1S/C28H27N3O3/c1-19-24(18-31-16-15-20-7-3-5-9-25(20)31)30-28(34-19)22-13-11-21(12-14-22)27(32)29-17-23-8-4-6-10-26(23)33-2/h3-14H,15-18H2,1-2H3,(H,29,32)
 
      
		
	   Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- N-[2-(2-chlorophenyl)ethyl]-3-pyrrol-1-yl-thieno[2,3-b]pyridine-2-carboxamide
- N-(2-ethylphenyl)-2-(4-oxidanylidene-7-pyrrolidin-1-ylsulfonyl-2,3-dihydro-1,5-benzothiazepin-5-yl)ethanamide
- N-(4-bromanyl-2-methyl-phenyl)-4-methyl-2-(4-methylphenyl)-3,5-bis(oxidanylidene)-1,2,4-triazine-6-carboxamide
- N-(2,6-dimethylphenyl)-2-(4-oxidanylidene-7-pyrrolidin-1-ylsulfonyl-2,3-dihydro-1,5-benzothiazepin-5-yl)ethanamide
- N-butan-2-yl-4-methyl-2-(4-methylphenyl)-3,5-bis(oxidanylidene)-1,2,4-triazine-6-carboxamide
- 2-(4-oxidanylidene-7-pyrrolidin-1-ylsulfonyl-2,3-dihydro-1,5-benzothiazepin-5-yl)-N-(2,4,6-trimethylphenyl)ethanamide
- ethyl 1-[[4-methyl-2-(4-methylphenyl)-3,5-bis(oxidanylidene)-1,2,4-triazin-6-yl]carbonyl]piperidine-4-carboxylate
- N-methyl-2-(4-oxidanylidene-7-pyrrolidin-1-ylsulfonyl-2,3-dihydro-1,5-benzothiazepin-5-yl)-N-phenyl-ethanamide
- 6-[4-(2-methoxyphenyl)piperazin-1-yl]carbonyl-4-methyl-2-(4-methylphenyl)-1,2,4-triazine-3,5-dione
- N-(3-fluorophenyl)-2-(4-oxidanylidene-7-pyrrolidin-1-ylsulfonyl-2,3-dihydro-1,5-benzothiazepin-5-yl)ethanamide

 
               
       
